Douglas Higgs |
MRC Molecular Haematology Unit, University of Oxford, United Kingdom Switching genes on and off during haematopoiesisWe are interested in the general question of how genes are switched on and off during cell fate decisions. We investigate both single loci and perform genome-wide analyses studying the changes in gene expression as multi-potent haematopoietic stem cells undergo lineage commitment and differentiation to form mature blood cells. We have an interest in understanding all cis-acting elements including enhancers, promoters, CpG islands, silencers and chromosomal boundary elements. We are particularly interested in enhancer-promoter interactions and how these respond to changes in the transcriptional programme and a wide variety of epigenetic influences including; non-coding RNAs, DNA modification, chromatin modifications, timing of DNA replication, chromosome conformation and nuclear sub-localisation. Ultimately, our aim is to use a systems-approach to integrate all such data and develop a model for how genes are regulated in vivo from within their natural chromosomal landscapes. Researchers associated with Epigenesys
|
Residing in the physical heart of the cell, the nucleus has now fully shed its once one-dimensional reputation as the repository for genetic information and steady supplier of messages to the cytoplasm. This sea change…
An open call for bilateral Franco-German projects in human epigenomics from the ANR-France has been announced! The deadline to submit a "declaration of intention" is March 29th, 2013. Click here for the announcement (in French).
Edith Heard, named a Chair of the Collège de France in Epigenetics and Cellular Memory will be giving weekly lectures starting in February that, in the tradition of this great institution, are free for anyone to attend. Lectures (in French) are from 16-17:30…
Watch the Nobel Prize winner, Sir John Gurdon, speak about winning the prize and about his revolutionary work on nuclear reprogramming.